Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Conditions characterized by impaired transmission of impulses at the neuromuscular junction. This may result from disorders that affect receptor function, pre- or postsynaptic membrane function, or acetylcholinesterase activity. The majority of diseases in this category are associated with autoimmune, toxic, or inherited conditions.
Biomarker and diagnostic research for neuromuscular junction disease has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy. Research is primarily sponsored by academic and government institutions.
15 publications have been identified in PubMed for neuromuscular junction disease. Research spans Review / Meta-Analysis (47%), Case Report / Case Series (20%), and Basic Science / Preclinical (13%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 7 | 47% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 6:50 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies |
3 |
20% |
Laboratory research | 2 | 13% |
Testing and diagnosis research | 1 | 7% |
Clinical study results | 1 | 7% |
New treatment approaches | 1 | 7% |
Qaisar R (2026). [PMID: 41686369](https://pubmed.ncbi.nlm.nih.gov/41686369/). *Cell Tissue Res*. [Review / Meta-Analysis]
Umay E (2026). [PMID: 41175271](https://pubmed.ncbi.nlm.nih.gov/41175271/). *Acta Neurol Belg*. [Review / Meta-Analysis]
Ren Z (2026). [PMID: 41686610](https://pubmed.ncbi.nlm.nih.gov/41686610/). *Medicine (Baltimore)*. [Basic Science / Preclinical]
Snape L (2026). [PMID: 42171767](https://pubmed.ncbi.nlm.nih.gov/42171767/). *Mamm Genome*. [Review / Meta-Analysis]
Gould TW (2025). [PMID: 38858074](https://pubmed.ncbi.nlm.nih.gov/38858074/). *Cold Spring Harb Perspect Biol*. [Review / Meta-Analysis]
Cao XG (2025). [PMID: 41476989](https://pubmed.ncbi.nlm.nih.gov/41476989/). *Front Immunol*. [Case Report / Case Series]
Jabara J (2025). [PMID: 40254244](https://pubmed.ncbi.nlm.nih.gov/40254244/). *J AAPOS*. [Case Report / Case Series]
Han HJ (2025). [PMID: 40281192](https://pubmed.ncbi.nlm.nih.gov/40281192/). *Neurol Sci*. [Clinical Trial Publication]
Fontana PN (2025). [PMID: 41331967](https://pubmed.ncbi.nlm.nih.gov/41331967/). *J Clin Neuromuscul Dis*. [Review / Meta-Analysis]
Moss KR (2025). [PMID: 41224659](https://pubmed.ncbi.nlm.nih.gov/41224659/). *J Neurosci*. [Review / Meta-Analysis]